Serum free light chain analysis in B-cell dyscrasias [2]

Annals of Clinical and Laboratory Science

Volumn 37, Issue 3, 2007, Pages 291-294

  Ramasamy, Indra ^a  

^a NEWHAM UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AMYLOIDOSIS; BLOOD DYSCRASIA; CLINICAL ARTICLE; FEMALE; HUMAN; LETTER; LIGHT CHAIN; MALE; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; B-LYMPHOCYTES; BLOOD PROTEIN ELECTROPHORESIS; FEMALE; HUMANS; IMMUNOGLOBULIN LAMBDA-CHAINS; MALE; MIDDLE AGED; MONOCLONAL GAMMOPATHIES, BENIGN; MULTIPLE MYELOMA; PROSPECTIVE STUDIES;

EID: 34548150639     PISSN: 00917370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (11)

1. Abadie JM, Bankson DD. Assessment of serum free light chain assays for plasma cell disorder screening in a veteran's affairs population. Ann Clin Lab Sci 2006;36:157-162.
2. Katzmann JA, Clark RJ, Abraham RS, Bryant S, Lymp JF, Bradwell AR, Kyle RA. Serum reference intervals and diagnostic ranges for free K and free L immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains. Clin Chem 2002;48:1437-1444.
3. Rajkumar SV, Kyle RA, Thernaeau TM, Melton J, Bradwell AR, Clark RJ, Larson DR, Plevak MF, Dispenzieri A, Katzmann JA. Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance. Blood 2005; 106:812-817.
4. Mead GP, Carr-Smith HD, Drayson MT, Morgan GJ, Child JA, Bradwell AR. Serum free light chains for monitoring multiple myeloma. Brit J Haem 2004;126, 348-354.
5. Tate J, Mollee P, Gill D. Serum free light chains for monitoring multiple myeloma. Brit J Haem 2005;128:405-409.
6. International Myeloma Working Group. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders. Brit J Haem 2003;121:749-757.
7. Myeloma management guidelines: a consensus report from the scientific advisors of the International Myeloma Foundation. Haematol J, 2003;4:379-398.
8. Smith A, Wisloff F, Samson D on behalf of the UK Myeloma Forum, Nordic Myeloma Study Group and British Committee for Standards in Haematology. Guidelines on the diagnosis and management of multiple myeloma. Brit J Haem 2005;132:410-451.
9. Tate JR, Gill D, Cobcroft R, Hickman PE. Practical considerations for the measurement of free light chains in serum. Clin Chem 2003;49,1252-1257.
10. Tate JR, Mollee P, Gill D. Measurement of immunoglobulin free light chains in serum. Clin Chem 2004;49:1957-1959.
11. Durie BGM, Harousseau J-L, Blade J, Barlogie B, Anderson K, Gertz M, Dimopoulos M, Westin J et al. International uniform response criteria for multiple myeloma. Leukemia 2006;20:1467-1473.